Experience With the Use of Rituximab for the Treatment of Rheumatoid Arthritis in a Tertiary Hospital in Spain: RITAR Study

There is evidence supporting that there are no relevant clinical differences between dosing rituximab 1000 mg or 2000 mg per cycle in rheumatoid arthritis (RA) patients in clinical trials, and low-dose cycles seem to have a better safety profile. Our objective was to describe the pattern of use of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Cañamares, Iciar, Merino, Leticia, López, Jorge, Llorente, Irene, García-Vadillo, Alberto, Ramirez, Esther, López-Bote, Juan Pedro, Benedí, Juana, Muñoz-Calleja, Cecilia, Álvaro-Gracia, José M., Castañeda, Santos, González-Álvaro, Isidoro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727960/
https://www.ncbi.nlm.nih.gov/pubmed/30001257
http://dx.doi.org/10.1097/RHU.0000000000000845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727960/
https://www.ncbi.nlm.nih.gov/pubmed/30001257
http://dx.doi.org/10.1097/RHU.0000000000000845

Ejemplares similares